Company intelligence / Profile preview
Xinqikang Pharmaceutical
Shanghai, Shanghai, Chinaqikang.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Xinqikang Pharmaceutical is a clinical-stage biotechnology company based in Shanghai, China, specializing in the discovery and development of innovative small molecule therapeutics. The company focuses primarily on endocrine-related diseases and oncology, with a particular emphasis on targeting nuclear receptors such as the estrogen and androgen receptors. Its lead programs are designed to address unmet medical needs in hormone-sensitive cancers, including advanced breast and prostate cancers. Xinqikang leverages its internal R&D capabilities to advance a pipeline of candidates through early-stage clinical trials in the Chinese market.
- Therapeutic areas
- OncologyEndocrinology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Xinqikang Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xinqikang Pharmaceutical.